[go: up one dir, main page]

DE177497T1 - IMMOBILIZATION OF NUCLEIC ACIDS. - Google Patents

IMMOBILIZATION OF NUCLEIC ACIDS.

Info

Publication number
DE177497T1
DE177497T1 DE198484901838T DE84901838T DE177497T1 DE 177497 T1 DE177497 T1 DE 177497T1 DE 198484901838 T DE198484901838 T DE 198484901838T DE 84901838 T DE84901838 T DE 84901838T DE 177497 T1 DE177497 T1 DE 177497T1
Authority
DE
Germany
Prior art keywords
dna
solid support
coupler
matrix system
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198484901838T
Other languages
German (de)
Inventor
W. Robert Frederick Md 21701 Blakesley
A. John Myersville Md 21773 Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Inc
Original Assignee
Life Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Inc filed Critical Life Technologies Inc
Publication of DE177497T1 publication Critical patent/DE177497T1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Claims (5)

1. NukI einsäure-Matriχ syst em, umfassend: einen festen Träger: ; 1. nuki einsäure-Matriχ syst em comprising: a solid support:; einen Kuppler, beinhaltend ein DNA-Molekül mit einem ersten und einem zweiten Ende, wobei das erste Ende kovalent an den festen Träger gebunden ist und das zweite Ende nicht an den festen Träger gebunden ist und eine Begrenzungs-Enzymhalbstelle darstellt; unda coupler including a DNA molecule with a first and second ends, the first end being covalently bonded to the solid support and the second End is not bound to the solid support and is a limiting enzyme half-site; and ein DNA-Molekül mit einem ersten Ende mit einer zu dem zweiten Ende des Kupplers komplementären Begrenzungs-Halbstelle, wobei das Molekül an der komplementären Halbstelle an das zweite Ende des Kupplers gekuppelt ist.a DNA molecule with a first end to that second end of the coupler complementary delimitation half-point, with the molecule at the complementary half-position is coupled to the second end of the coupler. 2. Matrixsystem nach Anspruch 1, wobei der Kuppler ein aus natürlich vorkommender DNA durch aufeinanderfolgende Behandlung der DNA mit zwei verschiedenen Begrenzungs-EndonukIeasen isoliertes Begrenzungs-Fragment umfaßt.2. Matrix system according to claim 1, wherein the coupler is one from naturally occurring DNA by successive Treatment of the DNA with two different limiting endonucleases isolated boundary fragment includes. 3. Matriχ sy st em nach Anspruch 2, wobei die natürlich vorkommende DNA aus der DNA des Plasmids pl)C9 erhalten wordenist.3. Matriχ sy st em according to claim 2, wherein the course occurring DNA obtained from the DNA of the plasmid pl) C9 has been. 4. " tfatrixsystem nach Anspruch 3, wobei die zwei ^verschiedenen Begrenzungs-EndonukLeasen BgI I und Hind III sind.4. The matrix system of claim 3, wherein the two ^ various limiting endonucleases BgI I and Hind III are. 5.Matrixsystem nach Anspruch 1, wobei der Kuppler OLigonükleötid und Mononukleotid umfaßt, wobei das .-'Wo.nonükleotid in vitro chemisch an das Ol igonukIeotid gebunden fwörden ist.5. The matrix system of claim 1, wherein the coupler is oligonucleotide and mononucleotide, wherein the .- 'Wo.nonucleotide in vitro chemically bound to the oligonucleotide is fwörden. 6. Matrixsystem nach Anspruch 5, wobei das OLigonukleotid ein synthetischer Ei rvz'ei strang mit der Basensequenz 5'-d(fpCp&pG)-3* ist.6. Matrix system according to claim 5, wherein the oligonucleotide a synthetic egg rvz'ei strand with the base sequence 5'-d (fpCp & pG) -3 * is. ■■?■. Matrixsystem nach Anspruch 6, wobei dem OligonukLeotid an sei riem 3'-OH-Ende ein bi ot i nyL i ertes Ribonuk Leot i d äiddiert worden ist.■■? ■. Matrix system according to claim 6, wherein the oligonucleotide at his 3'-OH end a bi ot i nyL i ertes Ribonuk Leot i d has been oathed. so. Matrixsystem nach Anspruch 7, wobei der feste Träger Ägarose ist, an der Streptavidiη kovaLent gebunden ist und wobei das biotinyLierte RibonukIeotid durch Kondensation äh das St reptavid i η gebunden worden ist.so. The matrix system of claim 7, wherein the solid support Agarose is bound to the Streptavidiη kovaLent and wherein the biotinyLierte RibonukIeotid by condensation uh that St reptavid i η has been tied. 9. Matrixsystem nach Anspruch 5, wobei das OLigonukLeotid ein·an seinem 3*-0H-Ende gebundenes RibonukLeotid aufweist.9. Matrix system according to claim 5, wherein the OLigonukLeotid a ribonucleotide bound at its 3 * -0H end having. '10 .Mat r i χ sys t em nach Anspruch 9, .wobei de r feste Träger ZeLLüLose ist, an der Adipinsäurehydrazid kovaLent gebunden ist und wobei das Ribonuk L eot id durc h Per j odatox idation in ein D.ialdehyd umgewandelt worden ist und wobei das Dia Idehyd durch Kondensation an das Adipinsäurehydrazid :gebunden worden ist.10 .Mat r i χ sys t em according to claim 9, .With the r solid support ZeLLüLose is covaLent bound to the adipic acid hydrazide is and where the Ribonuk leot id by perj odatox idation has been converted into a D.ialdehyde and the diaidehyde being converted to the adipic acid hydrazide by condensation : has been bound. 11. Matrixsystem nach Anspruch 1, wobei der feste Träger Zellulose ist, an der Adipinsäurehydrazid kovalent gebunden i st.11. The matrix system of claim 1, wherein the solid support Cellulose is covalently bound to the adipic hydrazide is. O Ί 77497O Ί 77497 12. Matrixsystem nach Anspruch 1, wobei der Kuppler ein Begrenzungs-Fragment und ein MononukLeotid umfaßt/ wobei das MononukLeotid in vitro chemisch an das Begrenzungs-Fragment gebunden worden ist.12. The matrix system of claim 1, wherein the coupler is a Boundary fragment and a mononucleotide comprises / wherein the mononucleotide has been chemically bound to the delimitation fragment in vitro. 13. Matrixsystem nach Anspruch 12, wobei das Begrenzungs-Fragment ein an seinem 3%-0H-Ende gebundenes RibonukIeotid aufwei st.13. Matrix system according to claim 12, wherein the delimitation fragment has a ribonucleotide bound to its 3% OH end. 14. Matrixsystem nach Anspruch 13, wobei der feste Träger Zellulose ist, ander Adi pinsäurehydrazid kovalent gebunden ist, wobei das RibonukIeotid durch Perjodatoxidation in ein Dialdehyd umgewandelt worden ist und wobei das Dialdehyd durch Kondensation an das Adipinsäurehydrazid gebunden worden ist. 14. Matrix system according to claim 13, wherein the solid carrier is cellulose, other Adi pi nsäu rehydrazid is covalently bound, wherein the RibonukIeotid has been converted by periodate oxidation in a dialdehyde and wherein the dialdehyde has been bound by condensation to the adipic acid hydrazide. 15. Matrixsystem nach Anspruch Λ, wobei der feste Träger Agarose ist/ an der streptavidin kovalent gebunden ist. 15. Matrix system according to claim Λ, wherein the solid support is agarose / is covalently bound to the streptavidin. 16. Kuppler-Matrixsystem umfassend: 16. Coupler matrix system comprising: einen festen Träger; unda solid support; and einen Kuppler mit einem Ende, das kovalent an den festen Träger gebunden ist und einem Abschnitt, der sich von dem gebundenen Ende erstreckt und eine Begrenzungsenzym-Rekognitions st el Ie enthält;a coupler having one end covalently bonded to the solid support and a portion which extends from the linked end and contains a limiting enzyme recognition post; wobei die Rekognitionsstel Ie aktiviert werden kann, um die Rekognitionsstel Ie in eine Begrenzungsenzym-Halbstelle umzuwandeln. wherein the Rekognitionsstel Ie can be activated to convert the Rekogni ti onsstel Ie into a limiting enzyme half-position. 17. Matrixsystem nach Anspruch 16, wobei der Kuppler ein aus natürlich vorkommender DNA durch aufeinanderfolgende Behandlung der DNA mit zwei verschiedenen Begrenzungs-EndonukIeasen isoliertes Begrenzungs-Fragment umfaßt.17. The matrix system of claim 16, wherein the coupler comprises a delimitation fragment isolated from naturally occurring DNA by sequentially treating the DNA with two different delimitation endonucleases. -A--A- 18. Matrix sy stem nach Anspruch 16, wobei der Kuppler ein Bregrenzungs-F ragment und eiη MpnonukLeotid umfaßt, wobei das, Mönonukleotid in vitro chemiseh an das Begrenzungs-Fr.agmeht g e b unden;worden i st.18. Matrix system according to claim 16, wherein the coupler comprises a limiting fragment and a mononucleotide, wherein the mononucleotide is chemically linked to the limiting fragment in vitro ; has been. 19i Hatrixsystem nach Anspruch16, wobei der feste Träger Zellulose ist, an der Adi pi nsäu rehyd razi d kpyaL ent gebunden ist.The matrix system of claim 16, wherein the solid support Cellulose is bound to the adipinic acid rehydrazi d kpyaL ent is. 20. ;Matrixsyst em nach Anspruch 17, wobei die natürlich yankommendeDNA aus der DNA des Plasmids pUC.9 erhalten worden ist.20th ; Matrix system according to claim 17, wherein the naturally arriving DNA has been obtained from the DNA of the plasmid pUC.9. 21. Matrixsyst em nach Anspruch 20, wobei die zwei verschiedenen Begrenzungs-EndonukIeasen BgI I und Hind III sind.21. The matrix system of claim 20, wherein the two various limiting endonucleases BgI I and Hind III are. 22> Matrixsystem nach Anspruch 18, wobei, dem Begrenzungs-Fragment an seinem 3'-0H-Ende ein RibonukLeptid addiert worden ist.22> Matrix system according to claim 18, wherein, the boundary fragment a ribonucleptide is added to its 3'-OH end has been. 23:. ;Mat r i χ sy st em nach Anspruch 22, wobei der feste Träger ZeIIuI öse ist, an der Adipinsäurehydrazid kovalent ge-■ ,bu.nde.-n, ist, wobei das R i bonuk I eot i d durch Perjodato,xidat..i.on in ein Dialdehyd umgewandelt worden ist und wobei das Dial.dehyd durch Kondensation an das Adipinsäurehydrazid gebunden worden ist.23 :. ; Mat ri χ system according to claim 22, wherein the solid support is cellular, on which adipic acid hydrazide is covalently bonded, where the ri bonuk I eot id by periodato, xidate .. i.on has been converted into a dialdehyde and the dialdehyde has been bonded to the adipic acid hydrazide by condensation. 2,4 . Kup.pl e r-Nuk Lei nsäu re-Sy st em, umfassend :2.4. Kup.pl e r-Nuk Lei nsäu re-Sy st em, comprising: ein DNA-MoLeküI mit einem ersten Ende mit einer ... Beg r enzung s enzym-H a lbstelle; unda DNA MoLeküI with a first end with a ... limitation of the enzyme holding point; and einen Kuppler, beinhaltend ein zweites DNA-Molekül mit einem ersten Ende mit einer zu der Begrenzungs-Halbstelle des ersten DNA-Moleküls komplementärena coupler including a second DNA molecule having a first end with one to the delimiting half-position of the first DNA molecule complementary Begrenzungsenzym-HaLbsteLLe, wobei das erste Ende an das Ende des ersten DNA-MoLeküLs gekuppeLt ist/ sowie ein zweites Ende, das mit einem festen Träger verbi ndba r ist.Limiting enzyme halves, with the first end is coupled to the end of the first DNA molecule / and a second end connectable to a solid support. 2 5. NukLeinsäuresystem nach Anspruch 24, wobei der KuppLer ein OLigonukLeotid umfaßt, an das Biotin addiert worden ist.2 5. Nucleic acid system according to claim 24, wherein the coupler an OLigonucleotide to which biotin has been added is. 26. NukLeinsäuresystem nach Anspruch 24, wobei die DNA ein Begrenzungs-EndonukLeasefragment ist.26. The nucleic acid system of claim 24, wherein the DNA is a limiting endonuclease fragment. 27. NukLeinsäuresystem nach Anspruch 25, wobei das OLigonukLeotid ein EinzeLstrang mit der Basensequenz 5%-d(TpCpGpG)-3l ist.27. Nucleic acid system according to claim 25, wherein the oligonucleotide is a single strand with the base sequence 5 % -d (TpCpGpG) -3 l . 28. NukLeinsäuresystem nach Anspruch 26, wobei die Begrenzungs-EndonukL ease Aval ist.28. The nucleic acid system of claim 26, wherein the limiting endonucL ease Aval is. 29. Verfahren zum Binden einer exponierten HaLbsteile einer BegrenzungssteLLe für eine gegebene Begrenzungs-EndonukLease an einen festen Träger, umfassend, in beliebiger Reihenfolge, das29. Method of Tying an Exposed Half-Piece a delimitation point for a given delimitation endonuclease to a solid support comprising, in any Order that kovalente Binden eines KuppLers, beinhaltend ein OLigonukLeotid, das die BegrenzungssteLLe enthält, an den festen Träger; undcovalent binding of a coupler, including a OLigonucleotide, which contains the delimitation point, to the solid support; and SpaLten des 0LigonukIeotids an der BegrenzungssteLLe mit der Begrenzungs-Endonuklease, um die exponierte Halbstelle zu erzeugen.Splitting of the oligonucleotide at the delimitation point with the limiting endonuclease to remove the exposed To generate half places. 30. Verfahren nach Anspruch 29, wobei der feste Träger eine Matrix aus Zellulose- oder Agarose-Adipinsäuredehydrazid ist und das chemische Binden des BgI I-Endes des Begrenzungs-Fragments an den festen Träger erreicht30. The method of claim 29, wherein the solid support a matrix of cellulose or agarose adipic acid dehydrazide and chemical bonding of the BgI I end of the boundary fragment to the solid support w i r d durchw i r d through Addition eines RibonukLeotids an das Ende der BgI I-Halbstelle des Begrenzungs-Fragments;Addition of a ribonucleus to the end of the BgI I half-position of the delimiting fragment; Oxidieren des RibonukLeotids mit Perjodat, um dessen Ribose-cis-Diöl in ein DiaLdehyd umzuwandeln; undOxidation of the ribonucleotide with periodate to reduce it Converting ribose-cis-di-oil into a dialdehyde; and Vermischen des■Begrenzungs-Fragments mit der Matrix.Mixing the boundary ■ fragment with the matrix. 31. Verfahren zum Binden einer exponierten Halbst el Ie einer Begrenzungsstelle für jede erwünschte der Begrenz ungs-Endonukleasen Hind III, Pst I, H inc II, BamH I, Sma I oder EcoR I an einen festen Träger, umfassend31. Method of Tying an Exposed Half-El Ie a restriction site for each of the desired restriction endonucleases Hind III, Pst I, H inc II, BamH I, Sma I or EcoR I to a solid support comprising das Isolieren aus Plasmid pUC9 DNA eines BgI I/Hind III-Begrenzungs-Fragments;isolating a Bgl I / Hind III boundary fragment from plasmid pUC9 DNA; chemisches Binden des BgI I-Endes des Begrenzungs-Fragments an den festen Träger; undchemically bonding the BgI I end of the limiting fragment to the solid support; and Spalten des Begrenzungs-Fragments mit der Begrenzungs-Endonuklease, für die eine exponierte 'Halbstelle erwünscht ist. Cleaving the boundary fragment with the boundary endonuclease for which an exposed half- digit is desired. 32. Verfahren zum Immobilisieren von DNA an einem festen Träger, umfassend das32. A method of immobilizing DNA on a solid support, comprising the stabile Binden an den festen Träger über ein Ende eines Oligonukleotids, das an seinem anderen Ende eine erste Ha Lbs teile für eine bekannte Begrenzungs-Endonuklease besitzt und für das die DNA eine Rekognitionsstelle für die Begrenzungs-Endonuklease enthält;stable binding to the solid support via one end of an oligonucleotide which at its other end has a first half of a known delimitation endonuclease and for which the DNA contains a recognition site for the delimitation endonuclease; Spalten der Begrenzungsstelle an der DNA mit der Begrenzungs-Endonuklease, um eine zweite und eine dritte Halbstelle an der DNA zu bilden; undColumns of the boundary point on the DNA to the limit endonuclease to form a second and a third half-site on the DNA; and Verbinden der ersten HalbsteLle entweder mit der zweiten oder der dritten HalbstelLe durch Behandlung mit DNA-L i gase.Connect the first half with either the second or the third half by treatment with DNA gas. 33. Verfahren zum Immobilisieren von DNA an einem festen Träger, umfassend das33. Method of immobilizing DNA on a solid Carrier, including that Binden der DNA an einen Oligonukleotid-Kuppler über korrespondierende Begrenzungs-Endonukleasen-Halbstellen, lokalisiert an einem Ende der DNA und einem ersten Ende des Kupplers; undBinding the DNA to an oligonucleotide coupler corresponding delimitation endonuclease halves, located at one end of the DNA and a first end of the coupler; and stabile· Binden des Kupplers an den festen Träger über ein zweites Ende des Kupplers.stable · binding of the coupler to the solid support over a second end of the coupler.
DE198484901838T 1984-04-05 1984-04-05 IMMOBILIZATION OF NUCLEIC ACIDS. Pending DE177497T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/000508 WO1985004674A1 (en) 1984-04-05 1984-04-05 Immobilization of nucleic acids

Publications (1)

Publication Number Publication Date
DE177497T1 true DE177497T1 (en) 1986-11-27

Family

ID=22182105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE198484901838T Pending DE177497T1 (en) 1984-04-05 1984-04-05 IMMOBILIZATION OF NUCLEIC ACIDS.

Country Status (4)

Country Link
EP (1) EP0177497A4 (en)
JP (1) JPS61501746A (en)
DE (1) DE177497T1 (en)
WO (1) WO1985004674A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818681A (en) * 1985-02-22 1989-04-04 Molecular Diagnostics, Inc. Fast and specific immobilization of nucleic acids to solid supports
EP0221108B1 (en) * 1985-05-02 1993-09-01 Genetics Institute, Inc. Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences
US5273882A (en) * 1985-06-13 1993-12-28 Amgen Method and kit for performing nucleic acid hybridization assays
US4751177A (en) * 1985-06-13 1988-06-14 Amgen Methods and kits for performing nucleic acid hybridization assays
JPS63502875A (en) * 1986-03-04 1988-10-27 ケンブリッジ バイオサイエンス コーポレーション Nucleic acid detection using particle aggregation
US4925785A (en) * 1986-03-07 1990-05-15 Biotechnica Diagnostics, Inc. Nucleic acid hybridization assays
US5047523A (en) * 1988-08-02 1991-09-10 Ortho Diagnostic Systems Inc. Nucleic acid probe for detection of neisseria gonorrhoea
US5759820A (en) * 1988-11-21 1998-06-02 Dynal As Process for producing cDNA
DE68922743T2 (en) * 1988-11-21 1995-10-26 Dynal As METHOD FOR PRODUCING CDNS.
US5324829A (en) * 1988-12-16 1994-06-28 Ortho Diagnostic Systems, Inc. High specific activity nucleic acid probes having target recognition and signal generating moieties
GR1000347B (en) * 1988-12-21 1992-06-25 Ortho Diagnostic Systems Inc Method of preparing nucleotide probes using a bridging complement
US5215882A (en) * 1989-11-30 1993-06-01 Ortho Diagnostic Systems, Inc. Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
FR2697851B1 (en) * 1992-11-10 1995-01-06 Bio Merieux System and method for detecting a nucleic acid sequence according to an amplification method by enzymatic restriction on a solid phase.
JP3612092B2 (en) * 1994-09-07 2005-01-19 株式会社日立製作所 DNA separation / sorting method and analysis method
US5783387A (en) * 1995-02-06 1998-07-21 The Regents Of The University Of California Method for identifying and quantifying nucleic acid sequence aberrations
US5731153A (en) * 1996-08-26 1998-03-24 The Regents Of The University Of California Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions
US5830655A (en) 1995-05-22 1998-11-03 Sri International Oligonucleotide sizing using cleavable primers
US6027879A (en) * 1995-08-09 2000-02-22 The Regents Of The University Of California Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
US5616465A (en) * 1995-08-09 1997-04-01 The Regents Of The University Of California Detection and isolation of nucleic acid sequences using competitive hybridization probes
US5747256A (en) * 1995-12-19 1998-05-05 Beckman Instruments, Inc. Homogeneous DNA probe titration assay
US6828435B2 (en) 1996-04-17 2004-12-07 Hk Pharmaceuticals, Inc. Combinatorial protecting group strategy for multifunctional molecules
AU748806B2 (en) * 1997-02-04 2002-06-13 Sequenom, Inc. A reversible stoichiometric process for conjugating biomolecules
EP0975807B1 (en) 1997-05-02 2006-09-27 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
GB9826247D0 (en) * 1998-11-30 1999-01-20 Nycomed Pharma As Method
JP2001204463A (en) * 2000-01-27 2001-07-31 Toyo Kohan Co Ltd Carrier for nucleotide immobilization
US20050074781A1 (en) * 2003-10-02 2005-04-07 Herbert von Schroeder Nucleic acid braided J-probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342833A (en) * 1977-05-31 1982-08-03 Bethesda Research Laboratory Immobilized restriction endonucleases
US4321365A (en) * 1977-10-19 1982-03-23 Research Corporation Oligonucleotides useful as adaptors in DNA cloning, adapted DNA molecules, and methods of preparing adaptors and adapted molecules
US4139346A (en) * 1977-11-28 1979-02-13 Enzo Bio Chem Incorporated Nucleic acid and protein binding paper
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
DE3211309A1 (en) * 1982-03-26 1983-09-29 Metin Dipl.-Ing. 6100 Darmstadt Colpan CHROMATOGRAPHIC METHOD FOR INSULATING MACROMOLECULES

Also Published As

Publication number Publication date
EP0177497A1 (en) 1986-04-16
EP0177497A4 (en) 1987-07-06
JPS61501746A (en) 1986-08-21
WO1985004674A1 (en) 1985-10-24

Similar Documents

Publication Publication Date Title
DE177497T1 (en) IMMOBILIZATION OF NUCLEIC ACIDS.
DE69304052D1 (en) BINDER COMPOSITIONS FOR GLASS FIBERS, METHOD FOR BINDING GLASS FIBERS AND GLASS FIBER COMPOSITIONS
DE68915919D1 (en) Electrically heated structural composite and process for its manufacture.
ATE169683T1 (en) METHOD FOR AMPLIFICATION OF NUCLEIC ACIDS ON A SOLID PHASE AND REAGENT SET THEREOF
EP0828849A4 (en) High-affinity oligonucleotide ligands to growth factors
DK0643778T3 (en) Coded combinatorial chemical libraries
DE69020376D1 (en) Process for the preparation of mono- or dicarboxylic acid substances which are substituted by long-chain hydrocarbons.
DE69307464D1 (en) Process for producing reinforced, composite composite structures, and composite structure produced by this method
DE69325970D1 (en) Wire rod, fine wire and twisted wire made of steel, process for the production of fine wire
DE68928336D1 (en) Process for the production of structural steels with high fire resistance and low yield strength ratio and structural steel produced thereby
DE69019640D1 (en) METHOD FOR PRODUCING BETA-1,3-GLUCAN IN ALGAE.
ATE76414T1 (en) POLYMERIZATE DISPERSIONS, PROCESS FOR THEIR PRODUCTION, AND THEIR APPLICATION AS BINDING AGENT.
NL1005627A1 (en) Tubes, preparation thereof and application.
DE3685368D1 (en) HIGH-STRENGTH AND HIGH-END STEEL RODS OR WIRE AND METHOD FOR THE PRODUCTION THEREOF.
DE3765043D1 (en) METHOD FOR PRODUCING CUT STRANDS FROM CARBON FIBERS AND SUCH STRANDS.
DE69500303T2 (en) METHOD FOR SEQUENCING SHORT OLIGONUCLEOTIDES
BR8903516A (en) REACTION PRODUCT, SOLUBLE IN OIL, USABLE AS I.V. DISPERSANT-PERFECTIVE, PROCESS FOR ITS PREPARATION, AND OIL COMPOSITION THAT CONTAINS IT
DE69014935D1 (en) Process for producing hardened aluminum alloy sheets with high strength and very good corrosion resistance.
WO1998016661A3 (en) Morphatides: novel shape and structure libraries
DE69301043D1 (en) Process for phosphating steel parts to improve their corrosion and wear resistance
EP1327005B1 (en) Method for selecting nucleic acids that bond with high-affinity to a target
EP0149634B1 (en) Process for the definite cross-linking of double helix dna fragments by means of a linkage dna as well as oligonucleotides used as linkage dna
DE59004407D1 (en) Multi-layer solid wood products such as beams, boards and glued beams as well as processes for their production.
ATE104389T1 (en) PROCESS FOR MANUFACTURING A PLASTIC MIXTURE BEAM OR COLUMN.
DE3871327D1 (en) METHOD FOR PRODUCING OBJECTS FROM HIGH-STRENGTH AND HIGH-STRENGTH STEEL.